Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-014432
Filing Date
2025-02-05
Accepted
2025-02-05 16:01:04
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3892
  Complete submission text file 0000950170-25-014432.txt   5376
Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address
Hayden Michael R (Reporting) CIK: 0001352908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39122 | Film No.: 25593133

Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Issuer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)